Abstract-Tris-oxazole macrolactone 2, a key intermediate of mycalolide B (1), which has 13 stereogenic centers, was synthesized through the use of ring-closing metathesis (RCM). The E/Z ratio of the RCM product 2 was reversed by the use of CH 2 Cl 2 and toluene, whereas a cross metathesis reaction yielded the C1-C35 long-chain compound 19 in a highly E-selective manner. Thus, the loss of flexibility in aliphatic carbon chains and the steric hinderance of β-and γ-substituents of the C20 olefin in the precursor 11 may affect the stereoselectivity in RCM reactions.
Mycalolide B (1) is a cytotoxic and antifungal macrolide isolated from the marine sponge Mycale sp. It bears a unique tris-oxazole structure and 13 stereogenic centers (Fig. 1) .
1 This compound also inhibits actomyosin Mg 2+ -ATPase and shows potent actin-depolymerizing activity by sequestering G-actin and forming a 1:1 complex.
2
Mycalolides can be divided into two characteristic parts: the C1-C24 macrolactone and the C25-C35 side-chain moieties. Studies of the structure-activity relationship 3 and photo-affinity labeling experiments 4 have established that the side-chain part of 1 is critically important for its ability to bind to and depolymerize actin. Several tris-oxazole macrolides closely related to mycalolides have been isolated, such as ulapualides, 5 halichondramides, 6 jaspisamides, 7 and kabiramides; 8 all of which exhibit potent actindepolymerizing properties. These agents may be useful for the development of novel pharmacological tools for analyzing actin-mediated cell functions, such as muscle contraction, cell motility, and cytokinesis. Furthermore, it is noteworthy that aplyronine A, which has an actin-binding side-chain moiety similar to mycalolides, exhibits potent antitumor activity in vivo against P388 leukemia and several cancers.
9,10 Thus, mycalolides and related actin-targeting natural products have great potential as preclinical candidates for use in cancer chemotherapy.
Due to their extraordinary structures and important biological activities, several synthetic studies on trisoxazole-containing macrolides have been reported. 11 Recently, total syntheses of mycalolide A 12 and ulapualide A 13 have been accomplished, in which Yamaguchi lactonization, cyclization of the central oxazole ring, or intramolecular Horner-Wadsworth-Emmons olefination were used to construct macrocycles. Subsequent studies have shown that olefin metathesis is a useful method for connecting the C19-C20 double bonds in mycalolide analogs.
14 Here we describe the synthesis of tris-oxazole macrolactone 2, a key synthetic intermediate of mycalolides, through the use of ring-closing metathesis (RCM). We expected that the convergent assembly of three fragments via Ni/Cr-mediated Nozaki-Hiyama-Kishi coupling 15 at C6-C7, esterification, and RCM at the C19-C20 olefin could efficiently afford 2. 
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The synthesis started with removal of the Boc and acetonide groups of the previously reported oxazole (-)- 3 14 under acidic conditions, and subsequent condensation with 2-chloroxazole-4-carboxylic acid 16 afforded amide 4 (77%, 2 steps) (Scheme 1). Due to the considerable instability of the 2-vinyloxazole moieties under basic and dehydration conditions, we planned to introduce the vinyl group to the oxazole ring after construction of the tris-oxazole structure. Dehydrating cyclization of 4 by diethylaminosulfur trifluoride (DAST) 17 gave an oxazoline intermediate (85%), which was oxidized with a combination of bromotrichloromethane and 1,8-diazabicycloundec-7-ene (DBU) 18 at room temperature to give tris-oxazole 5 (98% based on recovered starting material). 19 We found that acetonitrile is a better solvent than the conventional CH 2 Cl 2 in this reaction. Catalytic dihydroxylation of 5 with OsO 4 -NMO and Migita-Stille coupling with tri-n-butylvinyltin furnished a vinyloxazole intermediate, and this was transformed into aldehyde 6 via oxidative cleavage of the 1,2-diol with NaIO 4 (73%, 3 steps). Scheme 1. Synthesis of the RCM precursor 11. Reagents and conditions: (a) 3 M HCl, EtOAc, rt; (b) 2-chlorooxazole-4-carboxylic acid, EDCI·HCl, HOBt, Et3N, CH2Cl2, 0 °C to rt, 77% in 2 steps; (c) DAST, CH2Cl2, -78 to 0 °C, 85%; (d) DBU, BrCCl3, MeCN, rt, 54% (98% brsm); (e) OsO4, NMO, THFt BuOH-H2O, rt; (f) tri-n-butylvinyltin, PdCl2(PPh3)2, 1,4-dioxane, reflux; (g) NaIO4, EtOH-H2O, rt, 73% in 3 steps; (h) 7, CrCl2-NiCl2, THF-DMF, rt; (i) DMP, pyridine, CH2Cl2, rt, 71% in 2 steps; (j) TFA, CH2Cl2, 0 °C, 90%; (k) TBAF, THF, 40 °C, 97%; (l) 10, MNBA, Et3N, DMAP, CH2Cl2, rt, 55%.
Fragment coupling between 6 and vinyl iodide 7
12 by a Ni/Cr-mediated coupling reaction was followed by oxidation of the C7 allylic alcohol with Dess-Martin periodinane (DMP) 20 to afford a ketone (71%, 2 steps), the tert-butyl group of which was removed to give carboxylic acid 8 (90%). Removal of the tert-butyldimethylsilyl (TBS) group in 9 14,3b,21 by tetra-n-butylammonium fluoride (TBAF) gave C20-C35 fragment 10 (97%), which was condensed with 8 by the Shiina procedure 22 to afford the RCM precursor 11 in 55% yield.
With the key intermediate 11 in hand, RCM reactions were examined (Table 1) . First, treatment of 11 with 30 mol% of 2nd-generation Grubbs catalyst (12) 23 in degassed refluxing toluene led to decomposition of the starting material and gave a complex mixture (entry 1). We assumed that the low reactivity of 11 toward RCM reactions would be due to the electron-deficient C19 olefin. To overcome this problem, more thermally-stable and highly-active catalyst was considered. Treatment of 11 with 30 mol% of 2nd-generation Hoveyda-Grubbs catalyst (13) 24 in refluxing CH 2 Cl 2 (0.8 mM) yielded tris-oxazole lactone 2 as a separable 2:1 mixture of stereoisomers in 30% yield (entry 2). [25] [26] [27] With the use of toluene as a solvent (0.9 mM), the yield of 2 was improved to 76%, but the E/Z-product ratio was changed to 1:1.2 (entry 3). For comparison, we also used a cross-metathesis reaction (Scheme 2). Acidic treatment of cyanide 15 in aqueous MeOH, which was prepared from (S)-epichlorohydrin (14), 28 and protection of the hydroxyl group gave 16 (60% in 2 steps). Ozonolysis of the terminal olefin (80%) and Takai olefination 29 gave vinyl iodide 17 (66%, E/Z = 11/1).
Nozaki-Hiyama-Kishi coupling between compounds 6 and 17 gave an allylic alcohol (87%), which was oxidized with DMP to afford the C1-C19 ketone 18 in 84% yield. In contrast to the RCM reactions, treatment of the C1-C19 segment 18 (1.2 equiv.) and the C20-C35 segment 9 with 50 mol% of catalyst 13 in refluxing CH 2 Cl 2 (7 mM for 9) for 25 h yielded the C1-C35 long-chain compound 19 in a highly E-selective manner (66%, E/Z = 5:1). Our work demonstrated that the RCM reaction of 11 proceeded with low stereoselectivity, unlike the cross-metathesis reaction of 18. The E/Z ratios did not significantly change during the course of the metathesis reactions, and thus the formation of C=C bonds in 2 and 19 would take place under kinetic control. In the ruthenocyclobutane intermediate for the desired 19E-isomer of 2, the oxazole rings and C21-C35 alkyl chain are located in an anti-orientation. Due to the rigidness of the tris-oxazole and α,β-unsaturated ketone moieties, the anti-ruthenocyclobutane intermediate would be more strained than the syn-intermediate, which may affect the stereoselectivity in RCM reactions.
In conclusion, we achieved the synthesis of tris-oxazole macrolactone 2 through the use of RCM reactions as a key step, which includes all of the 13 stereogenic centers and the whole carbon framework of mycalolide B (1). Also, this key intermediate possesses a common framework for mycalolides and related actin-depolymerizing tris-oxazole macrolides. Studies on the total synthesis of mycalolide B (1) as well as on the stereoselectivity of RCM reactions, and especially solvent effects, are currently underway.
